Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.

@article{Lacouture2005TreatmentOR,
  title={Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.},
  author={Mario E. Lacouture and Joseph M. Baron and Ashesh B. Jani and Anne Laumann and Keyoumars Soltani},
  journal={Clinical and experimental dermatology},
  year={2005},
  volume={30 1},
  pages={46-8}
}
Primary cutaneous B cell lymphomas have a high recurrence rate after treatment with surgery and/or local radiation therapy. Two men are described in whom radiotherapy-relapsing cutaneous B-cell lymphomas were successfully treated with the monoclonal anti-CD20 antibody rituximab. Both patients had a complete response with no recurrence at follow-up at 17 and… CONTINUE READING